IP Library Granted Patent US 7,833,982
Granted Patent B2
US 7,833,982 · App. 12/154,660 · Granted Nov 16, 2010

Methods of treating dermal ulcers with thrombin derived peptides

Assignee: Orthologic Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,982
App. No.
12/154,660
Granted
Nov 16, 2010
Kind
B2
Abstract

Disclosed is a method of promoting healing of a chronic dermal skin ulcer, such as a diabetic ulcer, on a subject. The method comprises the step of contacting the chronic dermal skin ulcer with an effective amount of an agonist of the non-proteolytically activated thrombin receptor.

Claims (6)

1. A method of treating a diabetic ulcer below the kneecap in a diabetic subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO: 1, and wherein said polypeptide is administered alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent.

2. A method of treating a decubitus ulcer in a subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO: 1, and wherein said polypeptide is administered alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent.

3. A method of treating a diabetic ulcer below the kneecap in a diabetic subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO:1, wherein said polypeptide is administered alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent, and wherein the method further comprises debriding the ulcer, cleansing the ulcer, dressing the ulcer, and offloading pressure from the ulcer.

4. A method of treating a decubitus ulcer in a subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO: 1, wherein the polypeptide is administered alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent, and wherein the method further comprises debriding the ulcer, cleansing the ulcer, dressing the ulcer, and offloading pressure from the ulcer.

5. A method of treating a diabetic ulcer below the kneecap in a diabetic subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO: 1, and wherein the polypeptide is administered for a period of at least 32 days, alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent.

6. A method of treating a decubitus ulcer in a subject, the method comprising administering to the ulcer an effective amount of a polypeptide, wherein the amino acid sequence of the polypeptide is SEQ ID NO: 1, and wherein the polypeptide is administered for a period of at least 32 days, alone or in combination with an antimicrobial, a disinfectant, an antibiotic, an analgesic or an anti-inflammatory agent.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2011
From: CAPSTONE THERAPEUTICS CORP.
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 026804/0615 →
CHANGE OF NAME Recorded Aug 8, 2011
From: ORTHOLOGIC CORP.
To: CAPSTONE THERAPEUTICS CORP.
Reel/Frame 026715/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2008
From: CARNEY, DARRELL H.
To: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 022030/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2008
From: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: ORTHOLOGIC CORP.
Reel/Frame 022030/0702 →
CONFIRMATION OF ASSIGNMENT Recorded Dec 26, 2008
From: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: ORTHOLOGIC CORP.
Reel/Frame 022031/0462 →
Continuity (5)
Division 1139731000 · Apr 4, 2006
Continuation 1076675200 · Jan 27, 2004
Continuation PCTUS020115100 · Jan 16, 2002
Provisional Application 6030819800 · Jul 27, 2001
Related Publication 20090029923A1 · Jan 29, 2009